Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 6, 2005, Pages 423-430

  Beck, Stephen D W ^a   Foster, Richard S ^a   Bihrle, Richard ^a   Einhorn, Lawrence H ^b   Donohue, John P ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

RPLND; Serum tumor markers; Testicular cancer

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL TIME; TESTIS CANCER; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; HUMANS; INDIANA; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 27844453855     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.06.007     Document Type: Conference Paper

References (15)

1. E.W. Steyerberg, H.J. Keizer, S.D. Fossa Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor Multivariate analysis of individual patient data from six study groups J Clin Oncol 13 1995 1177 1187
2. E.P. Fox, T.D. Weathers, S.D. Williams Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections J Clin Oncol 11 1993 1294 1299
3. S.D.W. Beck, R.S. Foster, R. Bihrle Post chemotherapy desperation retroperitoneal lymph node dissection for patients with elevated serum tumor markers J Urol 165 2001 154 [Abstract 632]
4. P. Albers, A. Ganz, E. Hannig Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers J Urol 164 2000 381 384
5. D.P. Wood Jr, H.W. Herr, R.J. Motzer Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers Cancer 70 1992 2354 2357
6. J.A. Eastham, T.G. Wilson, C. Russell Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy Urology 43 1994 74 80
7. C.L. Coogan, R.S. Foster, R.G. Rowland Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone Urology 50 1997 957 962
8. B.R. Murphy, E.S. Breeden, J.P. Donohue Surgical salvage of chemorefractory germ cell tumors J Clin Oncol 11 1993 324 329
9. R. Ravi, J. Ong, R.T. Oliver Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours Br J Urol 81 1998 884 888
10. A. van der Gaast, J.W. Hoekstra, J.J. Croles Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma J Urol 145 1991 829 831
11. S.D. Beck, M.I. Patel, J. Sheinfeld Tumor marker levels in post-chemotherapy cystic masses Clinical implications for patients with germ cell tumors J Urol 171 2004 168 171
12. J.P. Donohue, I. Leviovitch, R.S. Foster Integration of surgery and systemic therapy Results and principles of integration Semin Urol Oncol 16 1998 65 71
13. J.M. McKiernan, R.J. Motzer, D.F. Bajorin Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor Clinical presentation, patterns of recurrence, and outcome Urology 62 2003 732 736
14. B.E. Davis, H.W. Herr, W.R. Fair The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy J Urol 152 1994 111 113
15. S.B. Saxman, C.R. Nichols, R.S. Foster The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers J Urol 155 1996 587 589